Friday 6 November 2026 Export DXCM’s income statement to Excel — free account

DexCom, Inc.

DXCM Healthcare Medical Devices

DexCom, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.7 billion, up 15.6% from fiscal 2024.

Revenue: +11.2%
EPS: 0.00%
Free cash flow: −52.9%
Total debt: +0.31%

Quarter to September 2026, against a year earlier

79.74 4.72 −5.59%

Follow DXCM

Alert me

Market cap: $31.5B
P/E: 32.6×
Fwd P/E: 31.8×
Dividend yield: —
F-score: 8/9
Altman Z: 6.43
Beneish M: −2.70
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

DexCom, Inc. (DXCM) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, DexCom, Inc. (DXCM) trades at a P/E ratio of 32.6×. Over the past ten years it has ranged from 0.0× (December 2019) to 311× (November 2018); the current reading is higher than 45% of that period. That is above the Medical Devices industry median of 25.6× and above the Healthcare sector median of 25.2×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/DXCM/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="DexCom, Inc. P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/DXCM/metrics/pe-ratio">DexCom, Inc. (DXCM) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	30.9×	(41.65%)
FY2024	52.9×	(39.40%)
FY2023	87.3×	(33.04%)
FY2022	130×	(53.62%)
FY2021	281×	292.28%
FY2020	71.7×	(64.30%)
FY2019	201×	—
FY2018	0.0×	—
FY2017	0.0×	—
FY2016	0.0×	—

Period	P/E ratio	Change
Sep 2026	33.3×	28.12%
Jun 2026	26.0×	(0.62%)
Mar 2026	26.2×	(15.24%)
Dec 2025	30.9×	(15.13%)
43 more quarters	Free account

Against its own ten years

Low 0.0× High 311×

Ten-year median 39.5×

Current reading's percentile 8

Company	P/E ratio
GKOS Glaukos Corporation compare	n/m
GEHC GE HealthCare Technologies Inc. compare	17.5×
BSX Boston Scientific Corporation compare	18.7×
PHG Koninklijke Philips N.V. compare	25.8×
ZBH Zimmer Biomet Holdings, Inc. compare	26.9×
STE STERIS plc compare	30.0×
DXCM DexCom, Inc.	32.6×
SNN Smith & Nephew SNATS, Inc. compare	38.9×
EW Edwards Lifesciences Corporation compare	56.7×
Medical Devices industry median	25.6×
Healthcare sector median	25.2×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

DexCom, Inc. (DXCM) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on DXCM

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on DXCM

Stockrow Weekly